The Efficacy and Safety of Teprotumumab in Thyroid Eye Disease: Evidence from Randomized Controlled Trials

Figure 5

Meta-analysis results from clinical trials for overall response (a), diplopia response (b), and CAS of 0 or 1 (c).

(a)

(b)

(c)